Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external video platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name Youtube
Purpose External media

Richtzenhain Award 2016: Call for Proposals

No. 17 | 12/04/2016 | by Koh

The Management Board of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) announces the Walther and Christine Richtzenhain Foundation Award 2016 for a scientific paper in translational cancer research. The prize is endowed with a sum of € 10.000.

© dkfz.de

The Richtzenhain foundation promotes cancer research in accordance with the founders' intentions, through two alternating awards. This year, scientific papers are being considered that are based on research carried out at an institution in Germany and that were published or accepted for publication in 2014 or 2015.

The focus should be on the successful transfer of scientific results into clinical applications. It is possible to submit multiple publications as long as they are thematically linked. Applications from scientists at an early stage of their career will be favored. The applicant's dissertation must have been completed within the last ten years. In a publication by several authors please indicate the individual contribution of the applicant.

A committee of experts will evaluate the applications. The award will be presented in a festive colloquium at the DKFZ in December 2016. Right of appeal is excluded.

Applications and proposals must be submitted in a set of five copies on a CD. The deadline is July 15th, 2016.

The CD should contain the following documents:

  • The letter of application
  • A current CV
  • A list of publications (at least within the last five years)
  • The scientific paper or papers.

 

Please send the application to the following address:

To the Scientific Director (interim) of the German Cancer Research Center,
Prof. Dr. Michael Boutros, Postbox 10 19 49, 69009 Heidelberg.

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institution in Germany. More than 1,300 scientists at the DKFZ investigate how cancer develops, identify cancer risk factors and search for new strategies to prevent people from developing cancer. They are developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to all questions on cancer.

Jointly with partners from the university hospitals, the DKFZ operates the National Center for Tumor Diseases (NCT) in Heidelberg and Dresden, and the Hopp Children's Cancer Center KiTZ in Heidelberg. In the German Consortium for Translational Cancer Research (DKTK), one of the six German Centers for Health Research, the DKFZ maintains translational centers at seven university partner locations. NCT and DKTK sites combine excellent university medicine with the high-profile research of the DKFZ. They contribute to the endeavor of transferring promising approaches from cancer research to the clinic and thus improving the chances of cancer patients.

The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS